NCT00307866View on ClinicalTrials.gov

Identification of Hepatic Lesions

PHASE3CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

April 30, 2001

Study Completion Date

May 31, 2003

Conditions
Hepatic Neoplasms
Interventions
PROCEDURE

Resovist (BAY86-4884, SH U 555 A)

Single bolus injection, followed by MRI

Trial Locations (19)

10154

Torino

16132

Genova

20132

Milan

20142

Milan

25123

Brescia

33100

Udine

34149

Trieste

37134

Verona

40100

Bologna

50100

Florence

56126

Pisa

66100

Chieti

67100

L’Aquila

70124

Bari

Unknown

Milan

Palermo

00144

Roma

07100

Sassari

00161

Roma

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00307866 - Identification of Hepatic Lesions | Biotech Hunter | Biotech Hunter